Revenue: US$13.0b (up 7.0% from FY 2023). Net income: US$746.0m (up 97% from FY 2023). Profit margin: 5.7% (up from 3.1% in FY 2023). The increase in margin was driven by higher revenue. EPS: US$8 ...

It was good to see Labcorp provide full-year revenue guidance that slightly topped analysts’ expectations. We were also happy its organic revenue was in line with Wall Street’s estimates.

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.8% year on year to $3.33 billion. The company’s full-year ...